These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8266406)
1. Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients. Alimohammadian MH; Kivanjah M; Pak F; Gaznavia A; Kharazmi A Trans R Soc Trop Med Hyg; 1993; 87(5):550-1. PubMed ID: 8266406 [No Abstract] [Full Text] [Related]
2. In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testing. Akuffo H; Darce M; Maasho K; Berhan TY Am J Trop Med Hyg; 1995 Jul; 53(1):16-22. PubMed ID: 7625529 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy of two leishmanins in asymptomatic dogs. Solano-Gallego L; Llull J; Arboix M; Ferrer L; Alberola J Vet Parasitol; 2001 Dec; 102(1-2):163-6. PubMed ID: 11705662 [TBL] [Abstract][Full Text] [Related]
4. The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis. Ben Salah A; Louzir H; Chlif S; Mokni M; Zaatour A; Raouene M; Ismail RB; Dellagi K J Infect Dis; 2005 Dec; 192(11):1981-7. PubMed ID: 16267771 [TBL] [Abstract][Full Text] [Related]
5. Leishmania major: species specific delayed hypersensitivity reaction induced by exogenous secreted antigen in the guinea pig. Khabiri AR; Bagheri F; Assmar M Exp Parasitol; 2006 Mar; 112(3):184-6. PubMed ID: 16376333 [TBL] [Abstract][Full Text] [Related]
6. [Concordance of leishmaniasis cutaneous tests in Tunisia]. Ben Alaya Bouafif N; Ben Salah A; Louzir H; Zaâtour A; Bel Haj Hamida N; Mighri F; Gharbi A; Gramiccia M; Gradoni L; Dellagi K; Ben Ismaïl R Arch Inst Pasteur Tunis; 2001; 78(1-4):11-6. PubMed ID: 14658234 [TBL] [Abstract][Full Text] [Related]
7. Leishmania major: common antigen responsible for induction of delayed-type hypersensitivity response in guinea pigs. Khabiri AR; Bagheri F; Assmar M Parasitol Res; 2007 Feb; 100(3):629-32. PubMed ID: 17013648 [TBL] [Abstract][Full Text] [Related]
8. Reevaluating leishmanin skin test as a marker for immunity against cutaneous leishmaniasis. Momeni Boroujeni A; Aminjavaheri M; Moshtaghian B; Momeni A; Momeni AZ Int J Dermatol; 2013 Jul; 52(7):827-30. PubMed ID: 23621513 [TBL] [Abstract][Full Text] [Related]
9. Use of Leishmania major derived leishmanin for skin test surveys of visceral leishmaniasis in Ethiopia. Hailu A; Berhe N; Ali A; Gemetchu T East Afr Med J; 1997 Jan; 74(1):41-5. PubMed ID: 9145577 [TBL] [Abstract][Full Text] [Related]
10. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Sassi A; Louzir H; Ben Salah A; Mokni M; Ben Osman A; Dellagi K Clin Exp Immunol; 1999 Apr; 116(1):127-32. PubMed ID: 10209516 [TBL] [Abstract][Full Text] [Related]
11. Response to heterologous leishmanins in cutaneous leishmaniasis in Nigeria--discovery of a new focus. Agwale SM; Duhlinska DD; Grimaldi Júnior G Mem Inst Oswaldo Cruz; 1998; 93(1):23-7. PubMed ID: 9698838 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a standardized leishmanin skin test in Guatemala. Arana BA; Roca M; Rizzo NR; Mendoza CE; Kroeger A Trans R Soc Trop Med Hyg; 1999; 93(4):394-6. PubMed ID: 10674085 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of leishmanin skin test and its relationship with the clinical form and duration of cutaneous leishmaniasis. Sadeghian G; Momeni A; Siadat AH; Yousefi P Dermatol Online J; 2006 Dec; 12(7):3. PubMed ID: 17459289 [TBL] [Abstract][Full Text] [Related]
14. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Kemp M; Hey AS; Kurtzhals JA; Christensen CB; Gaafar A; Mustafa MD; Kordofani AA; Ismail A; Kharazmi A; Theander TG Clin Exp Immunol; 1994 Jun; 96(3):410-5. PubMed ID: 8004809 [TBL] [Abstract][Full Text] [Related]
15. Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis. Reiter-Owona I; Rehkaemper-Schaefer C; Arriens S; Rosenstock P; Pfarr K; Hoerauf A Parasitol Res; 2016 Feb; 115(2):761-9. PubMed ID: 26508007 [TBL] [Abstract][Full Text] [Related]
16. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients. Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340 [TBL] [Abstract][Full Text] [Related]
17. Immunity Against Boussoffara T; Chelif S; Ben Ahmed M; Mokni M; Ben Salah A; Dellagi K; Louzir H Front Cell Infect Microbiol; 2018; 8():397. PubMed ID: 30483482 [TBL] [Abstract][Full Text] [Related]
18. Comparison of leishmanin skin test and direct smear for the diagnosis of cutaneous leishmaniasis. Hashemi SN; Mohebali M; Mansouri P; Bairami A; Hajjaran H; Akhoundi B; Charehdar S Acta Med Iran; 2011; 49(3):136-41. PubMed ID: 21681699 [TBL] [Abstract][Full Text] [Related]
19. Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited. Nylén S; Khamesipour A; Mohammadi A; Jafari-Shakib R; Eidsmo L; Noazin S; Modabber F; Akuffo H Vaccine; 2006 Nov; 24(47-48):6944-54. PubMed ID: 17049693 [TBL] [Abstract][Full Text] [Related]
20. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar. Zijlstra EE; el-Hassan AM Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]